{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:04:29Z","timestamp":1793822669027,"version":"4.6.1"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>As an autoimmune disease, IgA nephropathy is pathologically characterized by the deposition of immunoglobulin A (IgA) in the glomerular mesangial area. Recent research has confirmed that the activation of the lectin pathway in the complement system may be related to the development and prognosis of IgA nephropathy (IgAN). These deposited immune complexes trigger the complement cascade, generating various inflammatory mediators that directly attack glomerular mesangial cells and promote mesangial matrix proliferation and crescent formation, ultimately leading to end stage renal disease. Therefore, an in-depth understanding of complement activation pathways not only provides potential non-invasive biomarkers (such as urinary complement components) for assessing disease activity and prognosis, more importantly, establishes a theoretical foundation for developing novel anti-complement targeted therapies. This holds promise for opening new directions in the personalized precision treatment of IgA nephropathy. This article reviews the research progress on the lectin pathway and its associated components in IgA nephropathy.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1757595","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:51:21Z","timestamp":1772175081000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Research progress on the lectin pathway of complement in IgA nephropathy"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoqing","family":"Yu","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College of Binzhou Medical University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Urology, Zibo Central Hospital.","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifeng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Zibo Central Hospital","place":["Zibo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1436923","article-title":"Contemporary review of IgA nephropathy","volume":"15","author":"Filippone","year":"2024","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad199","article-title":"Ethnicity and IgA nephropathy: Worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis","volume":"16","author":"Lee","year":"2023","journal-title":"Clin Kidney J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"CJASN."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2018.05.013","article-title":"Epidemiology of IgA nephropathy: A global perspective","volume":"38","author":"Schena","year":"2018","journal-title":"Semin Nephrol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00884-7","article-title":"Is IgA nephropathy the same disease in different parts of the world","volume":"43","author":"Zhang","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: A defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-018-1619-6","article-title":"Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy","volume":"23","author":"Katafuchi","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.8.1984","article-title":"Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy","volume":"13","author":"Endo","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005090923","article-title":"Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease","volume":"17","author":"Roos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10238-018-0491-8","article-title":"The role of the alternative pathway of complement activation in glomerular diseases","volume":"18","author":"\u0141ukawska","year":"2018","journal-title":"Clin Exp Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00504","article-title":"The emerging role of complement proteins as a target for therapy of IgA nephropathy","volume":"10","author":"Rizk","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.28611","article-title":"Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis","volume":"38","author":"Hisano","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2215\/CJN.09710913","article-title":"Association of C4d deposition with clinical outcomes in IgA nephropathy","volume":"9","author":"Espinosa","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.11.015","article-title":"Progressive IgA nephropathy is associated with low circulating mannan-binding lectin\u2013associated serine protease-3 (MASP-3) and increased glomerular factor H\u2013related protein-5 (FHR5) deposition","volume":"3","author":"Medjeral-Thomas","year":"2018","journal-title":"Kidney Int Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-020-02800-0","article-title":"Complement activation is associated with crescent formation in IgA nephropathy","volume":"477","author":"Itami","year":"2020","journal-title":"Virchows Arch"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.03.003","article-title":"Complement: you gutsy thing","volume":"45","author":"Kemper","year":"2024","journal-title":"Trends Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/all.14413","article-title":"Mast cells and complement system: Ancient interactions between components of innate immunity","volume":"75","author":"Elieh Ali Komi","year":"2020","journal-title":"Allergy."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1042\/CS20257865","article-title":"Complement C3 in panvascular disease: a central integrator of immune signaling and vascular remodeling","volume":"139","author":"Li","year":"2025","journal-title":"Clin Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.67107.x","article-title":"IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells","volume":"67","author":"Novak","year":"2005","journal-title":"Kidney Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0306-z","article-title":"Glycosylation of IgA1 and pathogenesis of IgA nephropathy","volume":"34","author":"Novak","year":"2012","journal-title":"Semin Immunopathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1515\/med-2021-0239","article-title":"The ambiguous role of mannose-binding lectin (MBL) in human immunity","volume":"16","author":"Kalia","year":"2021","journal-title":"Open Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-021-00882-9","article-title":"Complement activation in IgA nephropathy","volume":"43","author":"Medjeral-Thomas","year":"2021","journal-title":"Semin Immunopathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1600-065X.2009.00789.x","article-title":"Mannose-binding lectin and innate immunity","volume":"230","author":"Eddie Ip","year":"2009","journal-title":"Immunol Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2017010076","article-title":"Mannose-binding lectin levels could predict prognosis in IgA nephropathy","volume":"28","author":"Guo","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-009-0924-1","article-title":"Mannose-binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children","volume":"168","author":"Chen","year":"2009","journal-title":"Eur J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jama.285.10.1316","article-title":"Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood","volume":"285","author":"Koch","year":"2001","journal-title":"JAMA."},{"key":"B29","article-title":"Identification of mannose-binding lectin as a mechanism in progressive immunoglobulin a nephropathy","volume":"8","author":"Shi","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"476739","DOI":"10.1155\/2012\/476739","article-title":"Pathological scenario with the mannose-binding lectin in patients with IgA nephropathy","volume":"2012","author":"Ohsawa","year":"2012","journal-title":"J BioMed Biotechnol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb05827.x","article-title":"The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response","volume":"90","author":"Thiel","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2147\/IJNRD.S8442","article-title":"Role of genetic polymorphisms in factor H and MBL genes in Tunisian patients with immunoglobulin a nephropathy","volume":"3","author":"Gorgi","year":"2010","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.09.036","article-title":"Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the korean population","volume":"42","author":"Lee","year":"2005","journal-title":"Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400520200","article-title":"Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein","volume":"279","author":"Larsen","year":"2004","journal-title":"J Biol Chem"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/003655901750292015","article-title":"Mannose-binding lectin gene polymorphism associated with the patterns of glomerular immune deposition in IgA nephropathy","volume":"35","author":"Gong","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"B36","article-title":"Genetic+variation+of+mannose-binding+protein+associated+with+glomerular+immune+deposition+in+IgA+nephropathy","volume":"115","author":"Gong","year":"2002","journal-title":"Advances in Clinical Chemistry"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00537","article-title":"A rare genetic defect of MBL2 increased the risk for progression of IgA nephropathy","volume":"10","author":"Ouyang","year":"2019","journal-title":"Front Immunol"},{"key":"B38","article-title":"Current topics in complement II","volume-title":"Advances in Experimental Medicine and Biology","author":"Lambris","year":"2008"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/ijms25031566","article-title":"The lectin pathway of the complement system\u2014activation, regulation, disease connections and interplay with other (proteolytic) systems","volume":"25","author":"Dob\u00f3","year":"2024","journal-title":"IJMS"},{"key":"B40","doi-asserted-by":"publisher","first-page":"105266","DOI":"10.1016\/j.phrs.2020.105266","article-title":"Emerging role of ficolins in autoimmune diseases","volume":"163","author":"Wang","year":"2021","journal-title":"Pharmacol Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad198","article-title":"Targeting complement in IgA nephropathy","volume":"16","author":"Caravaca-Font\u00e1n","year":"2023","journal-title":"Clin Kidney J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2007.01915.x","article-title":"The impact of FCN2 polymorphisms and haplotypes on the ficolin-2 serum levels","volume":"65","author":"Munthe-Fog","year":"2007","journal-title":"Scand J Immunol"},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2022.220417","article-title":"Serum proteomic analysis by nanoflow LC-MS\/MS-based proteomics in IgA chronic kidney disease","volume":"69","author":"Xue","year":"2023","journal-title":"Clin Lab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202403313R","article-title":"-3 activates complement and triggers necroptosis in cholangiocarcinoma cells via the <span style=\u201cfont-variant:Small-caps;\u201d>RIPK1\/RIPK3\/MLKL signaling pathway","volume":"39","author":"Zhang","year":"2025","journal-title":"FASEB J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2016.05.012","article-title":"The collectins CL-L1, CL-K1 and CL-P1, and their roles in complement and innate immunity","volume":"221","author":"Hansen","year":"2016","journal-title":"Immunobiology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002185","article-title":"Collectin 11 (CL-11, CL-K1) is a MASP-1\/3\u2013associated plasma collectin with microbial-binding activity","volume":"185","author":"Hansen","year":"2010","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.04.029","article-title":"IgA nephropathy: the lectin pathway and implications for targeted therapy","volume":"104","author":"Barratt","year":"2023","journal-title":"Kidney Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04300321","article-title":"Collectin11 and complement activation in igA nephropathy","volume":"16","author":"Wei","year":"2021","journal-title":"CJASN"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302121","article-title":"Heteromeric complexes of native collectin kidney 1 and collectin liver 1 are found in the circulation with MASPs and activate the complement system","volume":"191","author":"Henriksen","year":"2013","journal-title":"J Immunol"},{"key":"B50","article-title":"Pentraxin-3 and endothelial dysfunction","volume-title":"Advances in Clinical Chemistry","author":"Zlibuta","year":""},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00061.x","article-title":"Role of the soluble pattern recognition receptor PTX3 in vascular biology","volume":"11","author":"Presta","year":"2007","journal-title":"J Cell Mol Medi"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.3.1466","article-title":"The long pentraxin Ptx3 is synthesized in IgA glomerulonephritis and activates mesangial cells","volume":"170","author":"Bussolati","year":"2003","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03046","article-title":"Pentraxins in complement activation and regulation","volume":"9","author":"Ma","year":"2018","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.1002\/9780470015902.a0000508.pub3","article-title":"Complement System and Its Role in Immune Responses","volume-title":"Encyclopedia of Life Sciences","author":"Oikonomopoulou","year":"2012"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01750","article-title":"Regulation of the complement system by pentraxins","volume":"10","author":"Haapasalo","year":"2019","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae395","article-title":"Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity","volume":"18","author":"Nurmi","year":"2025","journal-title":"Clin Kidney J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.009225","article-title":"Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition","volume":"284","author":"Ma","year":"2009","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.190637","article-title":"Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system","volume":"286","author":"Ma","year":"2011","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5710","article-title":"Identification of the site of human mannan-binding lectin involved in the interaction with its partner serine proteases: The essential role of Lys55","volume":"178","author":"Teillet","year":"2007","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.5.2637","article-title":"Proteolytic activities of two types of mannose-binding lectin-associated serine protease","volume":"165","author":"Matsushita","year":"2000","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00161-3","article-title":"MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway","volume":"15","author":"Dahl","year":"2001","journal-title":"Immunity."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.25011\/cim.v45i3.38876","article-title":"Significance of mannan binding lectin-associated serine protease 2 in urinary extracellular vesicles in IgA nephropathy","volume":"45","author":"Wu","year":"2022","journal-title":"Clin Invest Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13208","article-title":"The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation","volume":"14","author":"Kozarcanin","year":"2016","journal-title":"J Thromb Haemostasis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014050429","article-title":"Complement factor C4d is a common denominator in thrombotic microangiopathy","volume":"26","author":"Chua","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz241","article-title":"Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin a nephropathy","volume":"36","author":"Trimarchi","year":"2021","journal-title":"Nephrol Dialysis Transplant"},{"key":"B66","doi-asserted-by":"publisher","first-page":"31877","DOI":"10.1038\/srep31877","article-title":"MASP-3 is the exclusive pro-factor D activator in resting blood: The lectin and the alternative complement pathways are fundamentally linked","volume":"6","author":"Dob\u00f3","year":"2016","journal-title":"Sci Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.065805","article-title":"A novel mannose-binding lectin\/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation","volume":"285","author":"Skjoedt","year":"2010","journal-title":"J Biol Chem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.446500","article-title":"Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway","volume":"288","author":"Megyeri","year":"2013","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.11.015","article-title":"Progressive IgA nephropathy is associated with low circulating mannan-binding lectin-associated serine protease-3 (MASP-3) and increased glomerular factor H-related protein-5 (FHR5) deposition","volume":"3","author":"Medjeral-Thomas","year":"2018","journal-title":"Kidney Int Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000636","article-title":"Proprotein convertase is the highest-level activator of the alternative complement pathway in the blood","volume":"206","author":"Oroszl\u00e1n","year":"2021","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303263","article-title":"Heterocomplex formation between MBL\/ficolin\/CL-11\u2013associated serine protease-1 and -3 and MBL\/ficolin\/CL-11\u2013associated protein-1","volume":"192","author":"Rosbjerg","year":"2014","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.2870","article-title":"The two major oligomeric forms of human mannan-binding lectin: Chemical characterization, carbohydrate-binding properties, and interaction with MBL-associated serine proteases","volume":"174","author":"Teillet","year":"2005","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jim.2011.08.006","article-title":"MAp19, the alternative splice product of the MASP2 gene","volume":"373","author":"Degn","year":"2011","journal-title":"J Immunol Methods"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014101000","article-title":"Current understanding of the role of complement in IgA nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.03.043","article-title":"Circulating complement factor H\u2013related proteins 1 and 5 correlate with disease activity in IgA nephropathy","volume":"92","author":"Medjeral-Thomas","year":"2017","journal-title":"Kidney Int"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560060201","article-title":"The internal thioester and the covalent binding properties of the complement proteins C3 and C4","volume":"6","author":"Law","year":"1997","journal-title":"Protein Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694928","article-title":"Complement C4, infections, and autoimmune diseases","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jim.2014.01.011","article-title":"A specific assay for quantification of human C4c by use of an anti-C4c monoclonal antibody","volume":"405","author":"Pilely","year":"2014","journal-title":"J Immunol Methods"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.12.6298","article-title":"Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells","volume":"168","author":"Barilla-LaBarca","year":"2002","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252638","article-title":"Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy","volume":"16","author":"Worawichawong","year":"2021","journal-title":"PloS One"},{"key":"B81","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4103\/1319-2442.336763","article-title":"Prognostic value of mesangial C4d staining in IgA nephropathy: A Tunisian study","volume":"32","author":"Jebali","year":"2021","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn563","article-title":"Mesangial C4d deposition: A new prognostic factor in IgA nephropathy","volume":"24","author":"Espinosa","year":"2008","journal-title":"Nephrol Dialysis Transplant"},{"key":"B83","article-title":"Prognostic value of glomerular C4d staining in patients with IgA nephritis","volume":"32","author":"Sahin","year":"2021","journal-title":"IgA Nephropathy"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2015.1077319","article-title":"IgA nephropathy: Association of C4d with clinical and histopathological findings and possible role of IgM","volume":"37","author":"Heybeli","year":"2015","journal-title":"Renal Fail"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2021.06.009","article-title":"Glomerular C4d deposition and kidney disease progression in IgA nephropathy: A systematic review and meta-analysis","volume":"3","author":"Jiang","year":"2021","journal-title":"Kidney Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.11.005","article-title":"Systematic review of the link between oxford MEST-C classification and complement activation in IgA nephropathy","volume":"9","author":"\u0218tefan","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.13315\/j.cnki.cjcep.2013.11.013","article-title":"C4d staining of the glomerular capillary loop a marker for disease progression of IgA ne- phropathy","volume":"29","author":"Jian-song","year":"2013","journal-title":"J Clin Exp Pathol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejim.2024.02.015","article-title":"The complement system in the pathogenesis and progression of kidney diseases: What doesn\u2019t kill you makes you older","volume":"124","author":"Stea","year":"2024","journal-title":"Eur J Internal Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome \u2014 the intracellular complement system","volume":"19","author":"West","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: An update from the IgA nephropathy classification working group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676919","article-title":"Complement activation is associated with crescents in IgA nephropathy","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17502","article-title":"Evaluation of crescent formation as a predictive marker in immunoglobulin a nephropathy: A systematic review and meta-analysis","volume":"8","author":"Shao","year":"2017","journal-title":"Oncotarget."},{"key":"B93","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1681\/ASN.2016040433","article-title":"A multicenter study of the predictive value of crescents in IgA nephropathy","volume":"28","author":"Haas","year":"2017","journal-title":"JASN."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac024","article-title":"The level of urinary C4d is associated with disease progression in IgA nephropathy with glomerular crescentic lesions: A cohort study","volume":"37","author":"Wang","year":"2022","journal-title":"Nephrol Dialysis Transplant"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy341","article-title":"Repeat renal biopsy improves the oxford classification-based prediction of immunoglobulin a nephropathy outcome","volume":"35","author":"Jullien","year":"2020","journal-title":"Nephrol Dialysis Transplant"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.03.017","article-title":"Arteriolar C4d in IgA nephropathy: A cohort study","volume":"76","author":"Faria","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.945913","article-title":"Overactivation of the complement system may be involved in intrarenal arteriolar lesions in IgA nephropathy","volume":"9","author":"Guo","year":"2022","journal-title":"Front Med (Laus)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.10.019","article-title":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis","volume":"93","author":"Suzuki","year":"2018","journal-title":"Kidney Int"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8210641","article-title":"Serial galactose-deficient IgA1 levels in children with IgA nephropathy and healthy controls","volume":"2017","author":"Sanders","year":"2017","journal-title":"Int J Nephrol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-023-01874-8","article-title":"Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: A systematic review and meta-analysis","volume":"37","author":"Vaz De Castro","year":"2024","journal-title":"J Nephrol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp294","article-title":"Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy","volume":"24","author":"Lin","year":"2009","journal-title":"Nephrol Dialysis Transplant"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-484X.2020.01.015","article-title":"Role of serum MASP2 and MASP3 in IgA nephropathy","volume":"36","author":"Zheng","year":"2020","journal-title":"Chinese Journal of Immunology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jcla.20154","article-title":"Hypercomplementemia in adult patients with IgA nephropathy","volume":"21","author":"Onda","year":"2007","journal-title":"J Clin Lab Anal"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141163","article-title":"Levels in plasma of the serine proteases and associated proteins of the lectin pathway are altered in patients with systemic lupus erythematosus","volume":"42","author":"Troldborg","year":"2015","journal-title":"J Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.09.020","article-title":"Evaluating progression risk in patients with immunoglobulin a nephropathy","volume":"8","author":"Cattran","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2016.11.019","article-title":"Study of the variables associated with local complement activation in IgA nephropathy","volume":"37","author":"Segarra-Medrano","year":"2017","journal-title":"Nefrologia."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae001","article-title":"Association between urinary C4d levels and disease progression in IgA nephropathy","volume":"39","author":"Dong","year":"2024","journal-title":"Nephrol Dialysis Transplant"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.3390\/jcm12216927","article-title":"A PRoliferation-inducing ligand (APRIL) in the pathogenesis of immunoglobulin a nephropathy: A review of the evidence","volume":"12","author":"Mathur","year":"2023","journal-title":"JCM."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015111210","article-title":"Fine mapping implicates a deletion of CFHR1 and CFHR3 in protection from IgA nephropathy in han Chinese","volume":"27","author":"Xie","year":"2016","journal-title":"JASN."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.5301\/jn.5000218","article-title":"Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features","volume":"26","author":"Xin","year":"2013","journal-title":"JN."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003099","article-title":"Increased APRIL expression induces igA1 aberrant glycosylation in igA nephropathy","volume":"95","author":"Zhai","year":"2016","journal-title":"Medicine."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.08.003","article-title":"Safety, tolerability and efficacy of narsoplimab, a novel MASP-2 inhibitor for the treatment of IgA nephropathy","volume":"5","author":"Lafayette","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2025.2500291","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: A randomized, double-blind, placebo-controlled phase 1 study","volume":"34","author":"Lin","year":"2025","journal-title":"Expert Opin Investig Drugs"},{"key":"B116","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572754","article-title":"Monitoring immune responses in igA nephropathy: biomarkers to guide management","volume":"11","author":"Selvaskandan","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1757595\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:51:24Z","timestamp":1772175084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1757595\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":117,"alternative-id":["10.3389\/fimmu.2026.1757595"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1757595","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"article-number":"1757595"}}